Pfizer Inc. (PFE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 9 |
| Ownership rank: | 48 |
| % of all portfolios: | 0.188% |
| Hold Price * : | $28.08 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Hillman Capital Management |
3.66 |
Add 7.21% |
187,937 |
5,277,000 |
| ≡ |
Torray Funds |
3.42 |
Reduce 3.37% |
776,455 |
21,803,000 |
| ≡ |
Harry Burn - Sound Shore |
2.70 |
Buy |
2,870,421 |
80,601,000 |
| ≡ |
Kahn Brothers Group |
2.41 |
Reduce 12.50% |
484,733 |
13,611,000 |
| ≡ |
Prem Watsa - Fairfax Financial Holdings |
1.43 |
Add 11.22% |
990,900 |
27,815,000 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
0.66 |
Reduce 8.49% |
1,914,219 |
53,751,000 |
| ≡ |
Richard Pzena - Pzena Investment Management |
0.54 |
Reduce 9.22% |
5,924,892 |
166,371,000 |
| ≡ |
Mairs & Power Funds |
0.02 |
Reduce 2.83% |
71,829 |
2,017,000 |
| ≡ |
Dodge & Cox Funds |
0.00 |
Reduce 1.99% |
88,564 |
2,487,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 14 Feb 2025 |
BLAYLOCK RONALD E |
Director |
13 Feb 2025 |
19,457 |
25.65 |
499,072 |
| 31 Oct 2024 |
GOTTLIEB SCOTT |
Director |
30 Oct 2024 |
1,000 |
28.24 |
28,240 |
| 19 Dec 2023 |
GOTTLIEB SCOTT |
Director |
15 Dec 2023 |
3,000 |
26.47 |
79,401 |
| 09 May 2023 |
GOTTLIEB SCOTT |
Director |
08 May 2023 |
1,000 |
38.58 |
38,580 |
| 09 May 2023 |
GOTTLIEB SCOTT |
Director |
05 May 2023 |
1,000 |
38.42 |
38,425 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock